{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:23Z","timestamp":1793766443197,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102630","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:26:19Z","timestamp":1784993179000},"page":"102630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1RAs Use and Postoperative Outcomes in T2DM Patients Undergoing Radical Nephrectomy"],"prefix":"10.1016","volume":"24","author":[{"given":"Sam","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2647-4848","authenticated-orcid":false,"given":"Diego","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4042-1511","authenticated-orcid":false,"given":"Fiona","family":"Wardrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4331-6353","authenticated-orcid":false,"given":"Josiah","family":"Dallmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5652-7204","authenticated-orcid":false,"given":"Kris","family":"Kokoneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clgc.2026.102630_bib0001","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3892\/ijmm.2016.2776","article-title":"Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: a review of the literature","volume":"38","author":"Labochka","year":"2016","journal-title":"Int J Mol Med"},{"issue":"27","key":"10.1016\/j.clgc.2026.102630_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000183","article-title":"Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma","volume":"93","author":"Vavallo","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clgc.2026.102630_bib0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7150\/jca.3718","article-title":"Diabetes and risk of renal cell carcinoma","volume":"3","author":"Habib","year":"2012","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2026.102630_bib0004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/iju.13028","article-title":"Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter longitudinal study","volume":"23","author":"Kawamura","year":"2016","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102630_bib0005","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.juro.2015.05.097","article-title":"Diabetes mellitus as an independent predictor of survival of patients surgically treated for renal cell carcinoma: a propensity score matching study","volume":"194","author":"Lee","year":"2015","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102630_bib0006","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1111\/dom.70010","article-title":"Comparative analysis on renal and cardiovascular outcomes of antidiabetic treatment in chronic kidney disease patients \u2013 a systematic review and network meta-analysis","volume":"27","author":"Bramlage","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1 Suppl 1","key":"10.1016\/j.clgc.2026.102630_bib0007","first-page":"S239","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.clgc.2026.102630_bib0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD","volume":"85","author":"Navaneethan","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"10296","key":"10.1016\/j.clgc.2026.102630_bib0009","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clgc.2026.102630_bib0010","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1111\/dom.70144","article-title":"Genetic evidence for repurposing GLP-1 receptor agonists in chronic kidney disease and IgA nephropathy: metabolic and anti-inflammatory pathways beyond glycaemic control","volume":"27","author":"Yang","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.clgc.2026.102630_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.kint.2023.09.029","article-title":"Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation","volume":"105","author":"Sourris","year":"2024","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.clgc.2026.102630_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.30952","article-title":"GLP-1 RAs and cardiovascular and kidney outcomes by body mass index in type 2 diabetes","volume":"8","author":"Chen","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.clgc.2026.102630_bib0013","doi-asserted-by":"crossref","first-page":"F443","DOI":"10.1152\/ajprenal.00280.2019","article-title":"Glucagon-like peptide-1 receptors in the kidney: impact on renal autoregulation","volume":"318","author":"Hviid","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102630_bib0014","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000048089","article-title":"Genetic evidence for a causal protective effect of GLP-1 receptor agonists on paralytic ileus but not on other gastrointestinal events","volume":"105","author":"Yuan","year":"2026","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.clgc.2026.102630_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf167","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential","volume":"19","author":"Colwill","year":"2025","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.clgc.2026.102630_bib0016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/imm.13784","article-title":"GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells","volume":"172","author":"Sun","year":"2024","journal-title":"Immunology"},{"issue":"16","key":"10.1016\/j.clgc.2026.102630_bib0017","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.clgc.2026.102630_bib0018","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.clgc.2026.102630_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713100","article-title":"Glucagon-like peptide-1 receptor activation reduces pulmonary vein arrhythmogenesis and regulates calcium homeostasis","volume":"24","author":"Chan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.clgc.2026.102630_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006740","article-title":"Modulation of cardiac ventricular excitability by GLP-1 (glucagon-like peptide-1)","volume":"11","author":"Ang","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"10.1016\/j.clgc.2026.102630_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094900","article-title":"Peptides are cardioprotective drugs of the future: the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like peptide-1 receptor agonists","volume":"25","author":"Boshchenko","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clgc.2026.102630_bib0022","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf703","article-title":"GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization","author":"Mahadevan","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clgc.2026.102630_bib0023","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1007\/s11357-024-01494-5","article-title":"Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types","volume":"47","author":"Ungvari","year":"2025","journal-title":"Geroscience"},{"issue":"7","key":"10.1016\/j.clgc.2026.102630_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.21887","article-title":"GLP-1 RA use and survival among older adults with cancer and type 2 diabetes","volume":"8","author":"Radwan","year":"2025","journal-title":"JAMA Netw Open"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:15:50Z","timestamp":1793765750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001308"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102630","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1RAs Use and Postoperative Outcomes in T2DM Patients Undergoing Radical Nephrectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102630"}}